Windlas Biotech's Board has approved a buyback of up to 4,70,000 equity shares, representing 2.23% of its total equity, for INR 47 Cr.

The shares will be bought back at INR 1,000 each via a tender offer, with promoters not participating.

Friday, April 24, 2026, is the record date to determine which shareholders are eligible to participate in this buyback offer.